Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
PHASE1
120 participants
INTERVENTIONAL
2025-10-01
2027-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. What combination of digital intervention components work best for postpartum mothers in home visiting programs?
2. What are the factors that help the intervention work best in home visiting, and what factors serve as barriers to the success of the intervention? Participants in the study will include home visiting staff and postpartum home visiting clients.
Participants who are home visitors will be asked to participate in focus groups and interviews, introduce the study to their clients and refer interested clients to the study, complete online surveys, and implement the home visitor components of the intervention with their clients who enroll in the study.
Participants who are home visiting clients will be asked to participate in focus groups and interviews, complete online surveys, and complete the digital screening and brief intervention sessions.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Indirect Assessment and Intervention for Perinatal Drug Use
NCT01650675
A Digital Intervention to Decrease Self-Stigma Among Pregnant and Postpartum Women With Substance Use Disorder
NCT07211867
Navigating New Motherhood 2
NCT03922334
Improving Maternal Mental Health & SUD Screening and Treatment
NCT05764213
Postpartum Intervention for Mothers With Opioid Use Disorders
NCT05614661
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Home visiting (HV), a strategy for delivering voluntary preventive services aimed at optimizing parent and child outcomes across the life course, is the primary supportive intervention offered to at-risk families during the perinatal period in the United States11,12. As HV is often one of the only service touchpoints for vulnerable families during the postpartum period, it is a promising venue for reaching new mothers to prevent risks associated with SU. However, the most widely used HV models do not have standardized protocols for identifying and addressing SU risk, beyond making referrals to community based services13, which leaves many mothers with unaddressed SU concerns that put themselves and their babies at risk. Our team has been working to fill this significant gap in services since 2013, and this study represents the next phase of our work, ultimately aimed at providing the HV field with a feasible and effective tool for managing perinatal SU and reducing associated risks to families.
Screening, Brief Intervention, and Referral to Treatment (SBIRT), originally designed to reduce gaps in the service continuum from primary care to SU treatment14,15, has been widely recommended as a public health model for addressing SU16-19. This approach may be a good fit for the HV context given its non-judgmental nature, the prevalence of low-to-moderate risk among HV clients, and the small proportion of HV clients who are actively seeking SU treatment20,21. Two key challenges preclude the successful integration of traditional SBIRT procedures into HV. First, HV clients are often reluctant to disclose SU to professionals, including HVrs, due to shame, stigma, denial, and fear of child removal22-25. Second, most HVrs are lay professionals, who lack the advanced clinical training and skills needed to effectively deliver evidence-based brief interventions (BI)26.
Screening and Brief Intervention (SBI) that is delivered digitally via computer or smartphone has great potential to overcome both of these challenges, as it does not require clients to directly disclose SU to a provider or providers to deliver evidence-based BIs. Digital SBI has been proven accessible and highly acceptable in postpartum mothers when delivered in healthcare settings, but shows small and inconsistent effects27,28. The BI literature suggests that extended intervention contacts may bolster BI effects29,30. Additional digital BI sessions and automated text messages are potential methods of extending BI impacts, and both have demonstrated acceptability in postpartum mothers. In a prior study, we developed an innovative digital SBI model that was tailored to the HV context (SBI-HV) that included an electronic SBI (e-SBI) that clients completed on their smartphones in between home visits, and a home visitor facilitation component to promote integration of the e-SBI into routine HV. The e-SBI applied motivational interviewing (MI) principles and the Feedback, Responsibility, Advice, Menu Options, Empathy, and Self-Efficacy BI framework. Confidentiality and preserving clients' choice regarding disclosing SU to their home visitor is core to SBI-HV. A small pilot study supported initial feasibility and acceptability of SBI-HV. Building on our prior R34, the proposed study aims to further optimize the SBI-HV by applying a factorial design to compare preliminary impacts of three SBI-HV delivery strategies: a single e-SBI session (main e-SBI), the main e-SBI session plus a booster session (booster e-SBI), and 4 weeks of tailored text messaging following e-SBI (text messaging). Additionally, we will systematically assess implementation facilitators and barriers to inform development of targeted implementation strategies to support sustainable integration of SBI-HV into routine HV.
The proposed R34 will use a Type 1 hybrid implementation-effectiveness design with a pilot 3X2 factorial trial and apply the RE-AIM and PRISM implementation frameworks to achieve the following specific aims:
1. Test the impact of 3 SBI-HV delivery strategies (main e-SBI; main e-SBI + booster e-SBI; and text messaging) on postpartum SU, maternal self-efficacy, motivation to avoid SU, and HV retention.
2. Evaluate feasibility, acceptability, fidelity, and facilitators and barriers to the 3 SBI-HV delivery strategies.
3. Develop tailored implementation strategies to support SBI-HV integration into routine HV.
We will partner with the Kansas Healthy Families (HF) multi-site HV system to complete study aims in 3 phases. All phases will be guided by the RE-AIM and PRISM implementation frameworks.
Phase 1: Pre-Implementation (Months 1-6): We will conduct a mixed-methods assessment of PRISM domains to inform SBI-HV implementation. Participants will include 36 home visitors, 36 clients, 12 supervisors, and 12 administrative staff representing all 12 Kansas HF programs. During this phase, we will assess program capacity and readiness to implement SBI-HV with the following goals: (a) select implementation program sites; (b) promote buy-in from key program staff; and (c) inform local adaptations to the SBI-HV.
Phase 2: Implementation (Months 7-25): We will conduct a pilot 3X2 factorial trial with 120 clients and 20 home visitors at 5 sites to obtain proof-of-concept data on the individual and combined impacts of the SBI-HV delivery strategies (main e-SBI, main e-SBI + booster, and text messaging) on SU, motivation, self-efficacy, and HV retention, as well as quantitative data on the RE-AIM domains.
Phase 3: Post-Implementation (Months 26-36): We will conduct qualitative interviews with home visitors, clients, supervisors, and administrative staff who participated in the factorial trial to systematically assess implementation facilitators and barriers using the RE-AIM and PRISM frameworks. Following assessment, we will conduct an iterative stakeholder-engaged process of developing candidate implementation strategies for testing in a future study.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
No intervention Routine HV Only
Routine home visiting only
No interventions assigned to this group
e-SBI main session
e-SBI main session
e-SBI main session
Single 20-minute e-SBI session that includes screening followed by brief motivational intervention.
e-SBI main session + booster
e-SBI main session and e-SBI booster session
e-SBI main session
Single 20-minute e-SBI session that includes screening followed by brief motivational intervention.
e-SBI Booster Session
A 20-minute booster e-SBI session that reinforces content from the main e-SBI session.
Text messaging only
text messaging
Text messaging
4 weeks of daily automated text messages that reinforce content from the e-SBI main session.
e-SBI main session + text messaging
e-SBI main session Text messaging
e-SBI main session
Single 20-minute e-SBI session that includes screening followed by brief motivational intervention.
Text messaging
4 weeks of daily automated text messages that reinforce content from the e-SBI main session.
e-SBI main + e-SBI booster + text messaging
e-SBI main session e-SBI booster session text messaging
e-SBI main session
Single 20-minute e-SBI session that includes screening followed by brief motivational intervention.
e-SBI Booster Session
A 20-minute booster e-SBI session that reinforces content from the main e-SBI session.
Text messaging
4 weeks of daily automated text messages that reinforce content from the e-SBI main session.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
e-SBI main session
Single 20-minute e-SBI session that includes screening followed by brief motivational intervention.
e-SBI Booster Session
A 20-minute booster e-SBI session that reinforces content from the main e-SBI session.
Text messaging
4 weeks of daily automated text messages that reinforce content from the e-SBI main session.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 18 years old or older
* Gave birth to a baby within the prior year
* Enrolled in a Healthy Families Kansas program with a participating home visitor
* Not currently enrolled in substance use treatment
Exclusion Criteria
* Under age 18 years
* Did not give birth to a baby within the prior year
* Not enrolled in a Healthy Families Kansas program with a participating home visitor
* Currently enrolled in substance use treatment
18 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Drug Abuse (NIDA)
NIH
The National Center on Addiction and Substance Abuse at Columbia University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sarah Dauber
Vice President
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HELP 3.0 Kansas
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.